Evidence map›Paper›PMID 30280664›Full record

ReviewCurrent drug metabolism2019

Survey of Drug Oxidation Activities in Hepatic and Intestinal Microsomes of Individual Common Marmosets, a New Nonhuman Primate Animal Model.

Shotaro Uehara, Toru Oshio, Kazuyuki Nakanishi, Etsuko Tomioka, Miyu Suzuki, Takashi Inoue, Yasuhiro Uno, Erika Sasaki, Hiroshi Yamazaki

Open access · bronzeAbstract readReview
In one paragraph

Review in Current drug metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Shotaro UeharaShowa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.
Toru OshioShowa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.
Kazuyuki NakanishiShowa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.
Etsuko TomiokaShowa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.
Miyu SuzukiShowa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.
Takashi InoueDepartment of Marmoset Research, Central Institute for Experimental Animals, Kawasaki, Japan.
Yasuhiro UnoShin Nippon Biomedical Laboratories, Ltd., Kainan, Wakayama, Japan.
Erika SasakiDepartment of Marmoset Research, Central Institute for Experimental Animals, Kawasaki, Japan.
Hiroshi YamazakiShowa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.
Showa Pharmaceutical University · JPCentral Institute for Experimental Animals · JPShin Nippon Biomedical Laboratories (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCommon marmosets (Callithrix jacchus) are potentially useful nonhuman primate models for preclinical studies. Information for major drug-metabolizing cytochrome P450 (P450) enzymes is now available that supports the use of this primate species as an animal model for drug development. Here, we collect and provide an overview of information on the activities of common marmoset hepatic and intestinal microsomes with respect to 28 typical human P450 probe oxidations.

resultsMarmoset P450 2D6/8-dependent R-metoprolol O-demethylation activities in hepatic microsomes were significantly correlated with those of midazolam 1'- and 4-hydroxylations, testosterone 6β-hydroxylation, and progesterone 6β-hydroxylation, which are probe reactions for marmoset P450 3A4/5/90. In marmosets, the oxidation activities of hepatic microsomes and intestinal microsomes were roughly comparable for midazolam and terfenadine. Overall, multiple forms of marmoset P450 enzymes in livers and intestines had generally similar substrate recognition functionalities to those of human and/or cynomolgus monkey P450 enzymes.

conclusionThe marmoset could be a model animal for humans with respect to the first-pass extraction of terfenadine and related substrates. These findings provide a foundation for understanding individual pharmacokinetic and toxicological results in nonhuman primates as preclinical models and will help to further support understanding of the molecular mechanisms of human P450 function.

Indexed as

CallithrixModels, AnimalAnimalsHumansIntestinal MucosaLiverMicrosomesOxidation-ReductionPharmaceutical PreparationsPharmaceutical PreparationsCYP2C19CYP2D6CYP3A4MarmosetPBPKPolymorphism.

Identifiers

PMID30280664
PMCPMC6635653
OpenAlexW2895546817

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.